These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 776718)

  • 1. Sensitivity of tumour and normal cells to the effect of immune lymphocytes in vitro and some properties of target cells determing this sensitivity.
    Lavrovsky VA; Razvorotnev VA
    Folia Biol (Praha); 1976; 22(2):108-15. PubMed ID: 776718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blocking effect of conditioned media from tumour cell cultures on the lysis of target cells by immune lymphocytes and macrophages.
    Lavrovsky VA; Tikhonov VJ; Rubzov NB; Razvorotnev VA
    Folia Biol (Praha); 1976; 22(2):101-7. PubMed ID: 1278566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential generation of killer or helper T-lymphocyte activity directed to the tumour-associated transplantation antigens.
    Fujiwara H; Hamaoka T; Teshima K; Aoki H; Kitagawa M
    Immunology; 1976 Aug; 31(2):239-48. PubMed ID: 1085283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histochemical studies on fatty acid in lymphocyte-mediated immune reaction.
    Cyong J; Okada H
    Immunology; 1976 May; 30(5):763-7. PubMed ID: 776819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Properties of cells determining their immunosensitivity].
    Lavrovskiĭ VA; Viksler VKh; Razvorotnev VA; Lobkov IuI
    Tsitologiia; 1977 Sep; 19(9):1018-23. PubMed ID: 563117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine Pam 212 cutaneous squamous cell carcinoma is nonimmunogenic in normal syngeneic hosts and resistant to immune effector mechanisms.
    Chen Z; Rosten SI; Lord EM; Gaspari AA
    Reg Immunol; 1993; 5(5):285-92. PubMed ID: 8148238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
    Prager MD; Granatek CH; Ludden CM
    Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated lymphoid cells: analysis of host cells that bind to syngeneic and allogeneic tumor cells shortly after tumor administration.
    Schick B; Berke B
    Transplant Proc; 1977 Mar; 9(1):1157-60. PubMed ID: 867485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.
    Fidler IJ; Gersten DM; Budmen MB
    Cancer Res; 1976 Sep; 36(9 pt.1):3160-5. PubMed ID: 975082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the cytotoxic effect of in vivo and in vitro immunized lymphocytes on liver target cells.
    Warnatz H; Scheiffarth F; Schmeissner R
    Clin Exp Immunol; 1975 Aug; 21(2):250-8. PubMed ID: 1081024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic determination of the immune response of mice to cells of various histological types].
    Lavrovskiĭ VA; Viksler VKh; Iurchenko IuA; Razvorotnev VA
    Genetika; 1978; 14(1):72-80. PubMed ID: 627344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
    Fidler IJ; Bucana C
    Cancer Res; 1977 Nov; 37(11):3945-56. PubMed ID: 908034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of interferon on the immune response of mice to immunization with the cells of transplantable leukemias and sarkomas].
    Skurkovich SV; Ol'shanskaia NV; Kalinina IA; Klinova EG; Eremkina EI
    Vopr Onkol; 1977; 23(9):44-50. PubMed ID: 910422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytotoxic antibodies against tumor cells in the blood of intact C3H mice].
    Lavrovskiĭ VA; Viksler VKh; Ustinov AS
    Biull Eksp Biol Med; 1979 May; 87(5):460-2. PubMed ID: 222378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.